Role of lipoprotein(a) in plaque progression

Identified by Berg in 1963, lipoprotein(a) represents a key contemporary residual risk pathway in atherosclerotic cardiovascular disease (ASCVD) secondary prevention. Indeed, epidemiological and genetic studies have undoubtedly demonstrated that lipoprotein(a) is one of the strongest causal risk fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruscica, Massimiliano, Rizzuto, Alessandra S, Corsini, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CCC 2022 - State of the Art Cardiology Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653156/
https://www.ncbi.nlm.nih.gov/pubmed/36380804
http://dx.doi.org/10.1093/eurheartjsupp/suac071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653156/
https://www.ncbi.nlm.nih.gov/pubmed/36380804
http://dx.doi.org/10.1093/eurheartjsupp/suac071

Ejemplares similares